Summary : Merck & Co Inc and partner Ridgeback Biotherapeutics said on Friday six lab studies showed their experimental oral COVID-19 drug molnupiravir…
API
-
-
AgrochemicalsIndia
Government Approves PLI Scheme to Promote Domestic API Production.
by adminby adminSummary : The total outlay of the scheme as decided by the government is Rs.6,940 crore. The scheme will provide financial incentives…
-
Agrochemicals
The United Kingdom becomes the First Country to Approve Molnupiravir Merck`s Oral Antiviral Drug
by adminby adminKEYPOINTS: The UK became the first country to approve Covid-19 antiviral pill, jointly developed by US-based Merck & Co Inc and Ridgeback…
-
India
The New Policy Draft By Indian Government to Empower Pharma – MedTech Sector
by adminby adminIntroduction The Medical Device industry is highly capital intensive with a long gestation period and requires development and induction of new technologies.…
-
Active Pharmaceutical Ingredients (API)Lenalidomide
Dr. Reddy’s Labs receives US FDA approval for Generic Revlimid (Lenalidomide).
by adminby adminKeypoints Dr. Reddy’s Laboratories said it has received approval from the US health regulator to market Lenalidomide capsules, used to treat multiple…
-
Active Agrochemical IngredientActive Pharmaceutical Ingredients (API)MolnupiravirRemdesivir
First Ever Pill for Covid-19, Molnupiravir Merck`s Antiviral Drug is being Manufactured by India`s Everest Organic Ltd.
by adminby adminKey points: India’s Everest Organics starts manufacturing Molnupiravir Active Pharmaceutical ingredient (API) for Merck’s COVID-19 pill. Everything you need to know about…
-
Agrochemicals
US FDA’s Center for Drug Evaluation and Research (CDER) – Novel Drug Approvals for 2021
by adminby adminUS FDA’s Center for Drug Evaluation and Research (CDER) – Novel Drug Approvals for 2021 Innovation drives progress. When it comes to…
-
Agrochemicals
PI Industries to Foray into Pharma Sector and Acquire – Ind-Swift to Sell API business
by adminby adminInd-Swift Laboratories will sell its Active Pharmaceutical Ingredients (API) business to PI Industries for an enterprise value of Rs 1,530 crore. The sale is expected…